Stericycle’s (SRCL) Hold Rating Reaffirmed at Robert W. Baird

Stericycle (NASDAQ:SRCL)‘s stock had its “hold” rating reaffirmed by investment analysts at Robert W. Baird in a research note issued on Tuesday.

The analysts wrote, “Driven by the successful turnaround efforts at Terminix and solid performance in FSG, adjusted EBITDA of $105M was in line with our estimate and beat the Street’s $101M estimate; revenues of $496M also beat our/Street’s $489M/$486M estimates. Management raised FY2018 revenue guidance to $1,885-1,900M ($1,875M-$1,890M previously), owing to the transformation efforts and performance of acquisitions at Terminix. The company reiterated adjusted EBITDA guidance of $425-435M, as it continues to invest in the business to create sustainable, long-term growth. Maintain Outperform.””

Several other equities research analysts have also recently commented on SRCL. Northcoast Research reaffirmed a “neutral” rating on shares of Stericycle in a research report on Friday, October 12th. BMO Capital Markets dropped their target price on Stericycle from $58.00 to $51.00 and set a “market perform” rating on the stock in a research report on Tuesday. Zacks Investment Research raised Stericycle from a “sell” rating to a “hold” rating in a research report on Monday, September 17th. Bank of America dropped their target price on Stericycle from $53.00 to $50.00 and set an “underperform” rating on the stock in a research report on Friday. Finally, BidaskClub raised Stericycle from a “buy” rating to a “strong-buy” rating in a research report on Tuesday, July 31st. Five analysts have rated the stock with a sell rating, four have issued a hold rating and three have given a buy rating to the stock. The company currently has a consensus rating of “Hold” and an average price target of $65.38.

Shares of Stericycle stock traded down $1.00 during trading on Tuesday, hitting $45.77. 11,100 shares of the company’s stock traded hands, compared to its average volume of 1,151,090. The company has a debt-to-equity ratio of 0.93, a current ratio of 1.07 and a quick ratio of 1.07. Stericycle has a 1 year low of $46.18 and a 1 year high of $76.73. The stock has a market capitalization of $4.06 billion, a PE ratio of 10.59, a price-to-earnings-growth ratio of 1.24 and a beta of 0.52.

Stericycle (NASDAQ:SRCL) last released its quarterly earnings data on Thursday, November 1st. The business services provider reported $1.03 EPS for the quarter, beating the consensus estimate of $1.01 by $0.02. Stericycle had a return on equity of 13.74% and a net margin of 4.63%. The company had revenue of $854.90 million for the quarter, compared to analysts’ expectations of $856.36 million. During the same period last year, the firm posted $1.10 earnings per share. Stericycle’s revenue was down 3.2% compared to the same quarter last year. As a group, sell-side analysts expect that Stericycle will post 4.37 EPS for the current fiscal year.

A number of large investors have recently made changes to their positions in the business. BlackRock Inc. boosted its position in Stericycle by 2.5% in the second quarter. BlackRock Inc. now owns 5,375,722 shares of the business services provider’s stock worth $350,980,000 after purchasing an additional 133,660 shares during the last quarter. Wells Fargo & Company MN raised its stake in shares of Stericycle by 0.8% in the third quarter. Wells Fargo & Company MN now owns 3,371,411 shares of the business services provider’s stock worth $197,834,000 after buying an additional 25,647 shares during the period. Clarkston Capital Partners LLC raised its stake in shares of Stericycle by 1.5% in the third quarter. Clarkston Capital Partners LLC now owns 2,528,045 shares of the business services provider’s stock worth $148,346,000 after buying an additional 36,635 shares during the period. FMR LLC raised its stake in shares of Stericycle by 18.5% in the second quarter. FMR LLC now owns 1,966,181 shares of the business services provider’s stock worth $128,372,000 after buying an additional 307,201 shares during the period. Finally, Fort Washington Investment Advisors Inc. OH raised its stake in shares of Stericycle by 1.4% in the second quarter. Fort Washington Investment Advisors Inc. OH now owns 966,240 shares of the business services provider’s stock worth $63,086,000 after buying an additional 13,640 shares during the period. 95.11% of the stock is currently owned by institutional investors and hedge funds.

Stericycle Company Profile

Stericycle, Inc, together with its subsidiaries, provides regulated and compliance solutions to the healthcare, retail, and commercial businesses in the United States and internationally. It collects and processes regulated and specialized waste for disposal services; and collects personal and confidential information for secure destruction, as well as offers training, consulting, recall/return, communication, and compliance services.

Featured Article: Return on Equity (ROE)

Analyst Recommendations for Stericycle (NASDAQ:SRCL)

Receive News & Ratings for Stericycle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stericycle and related companies with MarketBeat.com's FREE daily email newsletter.


Leave a Reply